Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (981-990 of 1,155) with videos related to

Pageof 116
Sort By:
Swiss Medical Weekly|August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancerArnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
NPJ Vaccines|December 4, 2021
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concernMitch Brinkkemper, Philip J M Brouwer, Pauline Maisonnasse, et al.
Thrombosis and Haemostasis|June 22, 2019
Sex Differences in the Association between Inflammation and Ischemic Heart DiseaseMichael Fiechter, Ahmed Haider, Susan Bengs, et al.
European Heart Journal. Cardiovascular Imaging|May 15, 2019
Association between resting amygdalar activity and abnormal cardiac function in women and men: a retrospective cohort studyMichael Fiechter, Andrea Roggo, Irene A Burger, et al.
Journal of the American Heart Association|October 1, 2019
Metabolic Activity in Central Neural Structures of Patients With Myocardial InjuryMichael Fiechter, Andrea Roggo, Ahmed Haider, et al.
The Journal of Biological Chemistry|December 10, 2017
Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimersSteven W de Taeye, Alba Torrents de la Peña, Andrea Vecchione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.
Iscience|April 17, 2023
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecovirusesLaura Radić, Kwinten Sliepen, Victor Yin, et al.
Blut|September 1, 1981
Germinal center cell lymphomas: prognostic significance of their histopathological differentiationE König, H Bartels, K Bremer, et al.
Blood Advances|June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studiesSteven E Coutre, John C Byrd, Peter Hillmen, et al.
Pageof 116

Showing results (981-990 of 1,155) with videos related to

Sort By:
Pageof 116
Swiss Medical Weekly|August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancerArnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
NPJ Vaccines|December 4, 2021
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concernMitch Brinkkemper, Philip J M Brouwer, Pauline Maisonnasse, et al.
Thrombosis and Haemostasis|June 22, 2019
Sex Differences in the Association between Inflammation and Ischemic Heart DiseaseMichael Fiechter, Ahmed Haider, Susan Bengs, et al.
European Heart Journal. Cardiovascular Imaging|May 15, 2019
Association between resting amygdalar activity and abnormal cardiac function in women and men: a retrospective cohort studyMichael Fiechter, Andrea Roggo, Irene A Burger, et al.
Journal of the American Heart Association|October 1, 2019
Metabolic Activity in Central Neural Structures of Patients With Myocardial InjuryMichael Fiechter, Andrea Roggo, Ahmed Haider, et al.
The Journal of Biological Chemistry|December 10, 2017
Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimersSteven W de Taeye, Alba Torrents de la Peña, Andrea Vecchione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.
Iscience|April 17, 2023
Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecovirusesLaura Radić, Kwinten Sliepen, Victor Yin, et al.
Blut|September 1, 1981
Germinal center cell lymphomas: prognostic significance of their histopathological differentiationE König, H Bartels, K Bremer, et al.
Blood Advances|June 15, 2019
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studiesSteven E Coutre, John C Byrd, Peter Hillmen, et al.
Pageof 116